Litcius/Paper detail

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Yohann Loriot, Aurélien Marabelle, Jean‐Philippe Guégan, François‐Xavier Danlos, Benjamin Besse, Nathalie Chaput, Christophe Massard, David Planchard, Caroline Robert, Caroline Even, Mohamed Khettab, Lambros Tselikas, Luc Friboulet, Fabrice André, Imane Nafia, François Le Loarer, Jean‐Charles Soria, Alban Bessede, Antoîne Italiano

2021Annals of Oncology87 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyBiomarkerImmunotherapyInternal medicineImmune checkpointCancerCohortProportional hazards modelTumor microenvironmentCancer researchImmunologyBioinformaticsBiologyBiochemistryCytokine Signaling Pathways and InteractionsImmune cells in cancerIL-33, ST2, and ILC Pathways
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance | Litcius